3351 - 3375 of 6230 Results
Title
Year
- A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene2021OPENTitle: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 106Issue #:Start Page: 343.e1End Page: 343.e8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.05.010Citation Count: 6
-
OPENTitle: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSFJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0130-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0130-3Citation Count: 21
- Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats2020OPENTitle: Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout ratsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 150Issue #:Start Page: 105246End Page: 105246Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105246Best OA location URL: https://doi.org/10.1016/j.nbd.2020.105246Citation Count: 18
- Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats2014OPENTitle: Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 ratsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 505End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.011Best OA location URL: https://uvadoc.uva.es/handle/10324/63882Citation Count: 47
-
OPENTitle: Orientation selective deep brain stimulationJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 14Issue #: 1Start Page: 016016End Page: 016016Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1088/1741-2552/aa5238Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5440185Citation Count: 48
-
OPENTitle: Distinct alterations in Parkinson's medication-state and disease-state connectivityJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 575End Page: 585Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004Best OA location URL: https://doi.org/10.1016/j.nicl.2017.09.004Citation Count: 44
-
OPENTitle: RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-024-03322-1Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12974-024-03322-1.pdfCitation Count: 0
- Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’S2016OPENTitle: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’SJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 14Issue #: 1Start Page: 13End Page: 15Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0087Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0087Citation Count: 0
- Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats2016OPENTitle: Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2016.01.020Best OA location URL: https://europepmc.org/articles/pmc4753102?pdf=renderCitation Count: 93
-
OPENTitle: New aspects of USP30 biology in the regulation of pexophagyJournal Name: AutophagyPublisher: Informa UK LimitedVol: 15Issue #: 9Start Page: 1634End Page: 1637Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2019.1615304Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2019.1615304?needAccess=trueCitation Count: 14
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 16
- Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations2016OPENTitle: Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 MutationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 11Start Page: e0166053End Page: e0166053Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0166053Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0166053&type=printableCitation Count: 18
- Mechanisms of Alpha-Synuclein-Seeded Aggregation in Neurons Revealed by Fluorescence Lifetime Imaging2025OPENTitle: Mechanisms of Alpha-Synuclein-Seeded Aggregation in Neurons Revealed by Fluorescence Lifetime ImagingJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00236Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.5c00236Citation Count: 0
- Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's disease2019OPENTitle: Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 123Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2019.09.015Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/226efa6a-7701-420c-935c-2c284c758e52Citation Count: 16
- Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration2018OPENTitle: Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy308Citation Count: 30
- Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)2021OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102569End Page: 102569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102569Best OA location URL: https://doi.org/10.1016/j.scr.2021.102569Citation Count: 2
- Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort2017OPENTitle: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 47Issue #:Start Page: 3End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5803409Citation Count: 47
-
OPENTitle: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian MonkeysJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30280Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30280Citation Count: 0
-
OPENTitle: Parkinson’s Disease Recognition Using SPECT Image and Interpretable AI: A TutorialJournal Name: IEEE Sensors JournalPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 21Issue #: 20Start Page: 22304End Page: 22316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/jsen.2021.3077949Best OA location URL: https://arxiv.org/pdf/1908.11199Citation Count: 29
-
OPENTitle: Il-10 signaling reduces survival in mouse models of synucleinopathyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00169-8Best OA location URL: https://www.nature.com/articles/s41531-021-00169-8.pdfCitation Count: 12
-
OPENTitle: POLCAM: instant molecular orientation microscopy for the life sciencesJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 10Start Page: 1873End Page: 1883Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41592-024-02382-8Best OA location URL: https://www.nature.com/articles/s41592-024-02382-8.pdfCitation Count: 5
- Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis2018OPENTitle: Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 50Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.006Best OA location URL: http://www.prd-journal.com/article/S1353802018300427/pdfCitation Count: 69
- Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein2022OPENTitle: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00322-xBest OA location URL: https://www.nature.com/articles/s41531-022-00322-x.pdfCitation Count: 9
- Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patients2015OPENTitle: Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patientsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 591Issue #:Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.02.013Best OA location URL: http://doi.org/10.1016/j.neulet.2015.02.013Citation Count: 11
- Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based Method2020OPENTitle: Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based MethodJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2095End Page: 2100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28175Citation Count: 29